Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4basebio Plc Regulatory News (4BB)

Share Price Information for 4basebio Plc (4BB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,080.00
Bid: 1,060.00
Ask: 1,100.00
Change: 0.00 (0.00%)
Spread: 40.00 (3.774%)
Open: 1,080.00
High: 1,080.00
Low: 1,080.00
Prev. Close: 1,080.00
4BB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

25 Feb 2021 09:00

RNS Number : 3347Q
4Basebio UK Societas
25 February 2021
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEGCGDDGGDDGBU

12
Date   Source Headline
10th Apr 20247:00 amPRN4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
21st Mar 20247:00 amPRN4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
1st Mar 20247:00 amPRN4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:01 amPRNHolding(s) in Company
6th Feb 20247:00 amPRNExercise of Options
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:01 amPRNHolding(s) in Company
5th Feb 20247:00 amPRNDirectors' Dealings
2nd Feb 20247:00 amPRNLong-Term Incentive Plan and Exercise of Options
21st Sep 20237:00 amPRNHalf-year Report
1st Aug 20237:00 amPRNGrant received from the Bill and Melinda Gates Foundation
27th Sep 20229:05 amRNSSecond Price Monitoring Extn
27th Sep 20229:00 amRNSPrice Monitoring Extension
6th May 20222:00 pmRNSPrice Monitoring Extension
23rd Mar 20227:00 amPRNRapidly Produced Customisable Synthetic DNA
15th Mar 20224:41 pmRNSSecond Price Monitoring Extn
15th Mar 20224:35 pmRNSPrice Monitoring Extension
15th Mar 20222:05 pmRNSSecond Price Monitoring Extn
15th Mar 20222:01 pmRNSPrice Monitoring Extension
15th Mar 202211:00 amRNSPrice Monitoring Extension
15th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20229:00 amRNSPrice Monitoring Extension
15th Feb 20227:00 amPRNDNA manufacturing update
18th Jan 20227:00 amPRNStrategic Research Collaboration
20th Dec 202112:49 pmPRNDirector/PDMR Shareholding
13th Dec 20213:55 pmPRNDirector/PDMR Shareholding
23rd Nov 20217:00 amPRNJoint Development Agreement with Leucid Bio
30th Sep 20217:00 amPRNHalf-year Report
28th Sep 20217:00 amPRNDevelopment of GMP Manufacturing Capacity
4th Aug 20214:40 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Jul 20213:39 pmPRNFurther re Conversion to UK PLC
21st Jul 20217:00 amPRNConversion to UK PLC
1st Jul 20214:09 pmPRNDirector/PDMR Shareholding
30th Jun 202112:50 pmPRNResult of AGM
22nd Jun 20217:00 amPRNApplication filed for protected linearised synthetic DNA
18th Jun 20217:00 amPRNAnnual General Meeting 2021
4th Jun 20217:00 amPRNNotice of AGM and Posting of Accounts
3rd Jun 20217:00 amPRNFinal Results
27th Apr 20217:00 amPRNEvaluation licence for muscular dystrophy vector
26th Feb 20217:00 amPRNDirector/PDMR Shareholding
25th Feb 20219:05 amRNSSecond Price Monitoring Extn
25th Feb 20219:00 amRNSPrice Monitoring Extension
22nd Feb 202111:00 amRNSPrice Monitoring Extension
22nd Feb 20219:31 amPRNHolding(s) in Company
19th Feb 20215:35 pmPRNHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.